ZENITH20, a multinational, multi-cohort phase II study of poziotinib in NSCLC patients with EGFR or HER2 exon 20 insertion mutations Meeting Abstract

International Collaboration

cited authors

  • Socinski, M. A.; Cornelissen, R.; Garassino, M. C.; Clarke, J.; Tchekmedyian, N.; Molina, J.; Goldman, J. W.; Bhat, G.; Lebel, F.; Le, X.

authors

Publication Date

  • September 1, 2020

webpage

published in

category

start page

  • S1188

end page

  • S1188

volume

  • 31